US3642444A - Analytical reagent and method for carbohydrate analysis in body fluids - Google Patents
Analytical reagent and method for carbohydrate analysis in body fluids Download PDFInfo
- Publication number
- US3642444A US3642444A US821470A US3642444DA US3642444A US 3642444 A US3642444 A US 3642444A US 821470 A US821470 A US 821470A US 3642444D A US3642444D A US 3642444DA US 3642444 A US3642444 A US 3642444A
- Authority
- US
- United States
- Prior art keywords
- acid
- reagent
- dimethylsulfoxide
- toluidine
- glucose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title claims abstract description 65
- 239000003153 chemical reaction reagent Substances 0.000 title claims abstract description 54
- 210000001124 body fluid Anatomy 0.000 title claims abstract description 39
- 239000010839 body fluid Substances 0.000 title claims abstract description 39
- 238000012511 carbohydrate analysis Methods 0.000 title description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 97
- 239000002253 acid Substances 0.000 claims abstract description 42
- 150000004982 aromatic amines Chemical class 0.000 claims abstract description 29
- 150000001312 aldohexoses Chemical class 0.000 claims abstract description 6
- 150000001320 aldopentoses Chemical class 0.000 claims abstract description 6
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 claims description 103
- RNVCVTLRINQCPJ-UHFFFAOYSA-N o-toluidine Chemical group CC1=CC=CC=C1N RNVCVTLRINQCPJ-UHFFFAOYSA-N 0.000 claims description 74
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 53
- 239000008103 glucose Substances 0.000 claims description 53
- 235000006408 oxalic acid Nutrition 0.000 claims description 37
- 230000003287 optical effect Effects 0.000 claims description 33
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 30
- 238000010438 heat treatment Methods 0.000 claims description 27
- 238000006243 chemical reaction Methods 0.000 claims description 21
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 16
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 16
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 16
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 15
- 239000012530 fluid Substances 0.000 claims description 15
- 239000000126 substance Substances 0.000 claims description 11
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims description 8
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 claims description 6
- 229940097043 glucuronic acid Drugs 0.000 claims description 6
- 230000001419 dependent effect Effects 0.000 claims description 5
- 230000001737 promoting effect Effects 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 4
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 claims 1
- 235000011007 phosphoric acid Nutrition 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 150000001720 carbohydrates Chemical class 0.000 description 11
- 235000014633 carbohydrates Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000009835 boiling Methods 0.000 description 9
- 210000002381 plasma Anatomy 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- 150000001412 amines Chemical class 0.000 description 6
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 5
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- -1 aldopentoses aldohexoses Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 3
- CZZZABOKJQXEBO-UHFFFAOYSA-N 2,4-dimethylaniline Chemical compound CC1=CC=C(N)C(C)=C1 CZZZABOKJQXEBO-UHFFFAOYSA-N 0.000 description 2
- VOWZNBNDMFLQGM-UHFFFAOYSA-N 2,5-dimethylaniline Chemical compound CC1=CC=C(C)C(N)=C1 VOWZNBNDMFLQGM-UHFFFAOYSA-N 0.000 description 2
- UFFBMTHBGFGIHF-UHFFFAOYSA-N 2,6-dimethylaniline Chemical compound CC1=CC=CC(C)=C1N UFFBMTHBGFGIHF-UHFFFAOYSA-N 0.000 description 2
- MKARNSWMMBGSHX-UHFFFAOYSA-N 3,5-dimethylaniline Chemical compound CC1=CC(C)=CC(N)=C1 MKARNSWMMBGSHX-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 150000002913 oxalic acids Chemical class 0.000 description 2
- 150000003016 phosphoric acids Chemical class 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- KCCNQSDIHGHVMV-SSPAHAAFSA-N 2-methylaniline;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound CC1=CC=CC=C1N.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O KCCNQSDIHGHVMV-SSPAHAAFSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WDFQBORIUYODSI-UHFFFAOYSA-N 4-bromoaniline Chemical compound NC1=CC=C(Br)C=C1 WDFQBORIUYODSI-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- MOXIHQGVDKOYGK-UHFFFAOYSA-N CS(=O)C.C(C(=O)O)(=O)O Chemical compound CS(=O)C.C(C(=O)O)(=O)O MOXIHQGVDKOYGK-UHFFFAOYSA-N 0.000 description 1
- 108700001574 Pentosuria Proteins 0.000 description 1
- 241001147416 Ursus maritimus Species 0.000 description 1
- 239000012445 acidic reagent Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 208000001893 pentosuria Diseases 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
- Y10T436/143333—Saccharide [e.g., DNA, etc.]
- Y10T436/144444—Glucose
Definitions
- This invention relates to a new and improved reagent and a method for its use in the, quantitative determination of aldopentoses aldohexoses, or their derivatives (e.g., glucose, arabinose, xylose, glucuronic acid, etc.) in a body fluid (e.g., whole blood, blood serum, blood plasma, urine, etc.).
- a body fluid e.g., whole blood, blood serum, blood plasma, urine, etc.
- the novel analytical reagent of the present invention comprises a solution of a. dimethylsulfoxide
- the present invention further relates to an improvement in the method forthe quantitative determination of a body chemical selected from the group consisting of aldopentoses, aldohexoses or their derivatives in a body fluid sample, comprising reacting the body chemical with an aromatic amine to form, with heating, a colored liquid having a optical density dependent upon the concentration of the carbohydrate in the body fluid.
- the improvement comprises carrying out the reaction in the presence of an acid capable of promoting the reaction in dimethylsulfoxide, and in the presence of sufficient dimethylsulfoxide to render the aromatic amine, the acid, and the body fluid sample soluble in the reagent.
- the method of the present invention may be carried out as follows: 4
- a measured sample of the body fluid e.g., blood serum
- a carbohydrate e.g., glucose
- an aromatic amine e.g., o-toluidine
- o-toluidine which.is capable, with heating, of reacting with glucose in the presence of oxalic acid to form a colored reaction product
- an acid e.g., oxalic acid which is capable of proiriot- ,7
- a color forming reaction betwe'iimtoluidine and glucose in dimethylsulfoxide; and 3. dimethylsulfoxide in sufiicient quantity to render the aromatic amine, the acid, and the body fluid sample soluble in the reagent.
- the resulting solution is heated (e.g., by placing a glass tube containing the solution into boiling water) for a short period (e.g., 4 to 10 minutes) and is then cooled to room temperature. During heating, the reaction between the carbohydrate and the aromatic amine produces a colored product which colors the solution.
- the optical density of the colored solution is measured at a wavelength which is characteristic of the absorption of the colored product.
- the measured optical density is correlated with the concentration of the carbohydrate in the body fluid by known means.
- Acids which may be employed in the present invention are characterized by their ability to promote a color forming reaction between glucose and o-toluidine in dimethylsulfoxide with heating.
- Usefulness of a candidate acid in the present invention may be determined as follows: To each of a number of test tubes, each containing ml. of dimethylsulfoxide, is added from 0.01 to 0.25 moles of the candidate acid. Thereafter, to each tube is sequentially added 4.0 ml. of otoluidine and 0.5 ml. of an aqueous glucose solution having a concentration of 100 milligrams ofglucose per 100 ml. of solution. After brief agitation, each tube is heated in boiling water for 6 minutes.
- Coloration of the solution in any of the tubes indicates that the candidate acid may be employed in the present invention.
- examples of such acids include oxalic acid, phosphoric acid, sulfuric acid, phthalic acid and hydrochloric acid.
- Oxalic and phosphoric acids are especially preferred because the colored solutions which are obtainable through the use of such acids in the dimethylsulfoxide reaction medium unexplainably exhibit much more intense colors than do the colored solutions of Hultman. Such intense coloration appears to depend primarily upon the selection of oxalic or phosphoric acid as the acid component rather than upon the selection of a specific aromatic amine.
- the intense coloration obtainable by the use of oxalic acid greatly increases the sensitivity of the system and is believed to be primarily responsible for the unusual capability of the present invention t determine the .concentration of such carbohydrates as, for example, arabinose, xylose and glucuronic acid in body fluids.
- the present invention may employ other acids in the detering, a colored product with glucose in the presence of oxalic acid and dimethylsulfoxide.
- 4 ml. of the amine are added to 100 ml. of dimethylsulfoxide containing 6.0 g. of oxalic acid in a test tube. To the resulting solution is added 0.5 ml.
- aromatic amine examples include otoluidine, 2,6-dimethyl aniline, and 2,5-dimethyl aniline (as reported by Hultman, supra.) and such other amines as p-bromoaniline, 3,5- dimethyl aniline and 2,4-dimethyl aniline.
- the reagent of the present invention will tolerate the inclusion therein of numerous other components. For example, quantities of methanol, ethanol and isopropanol may be added to the reagent without significant adverse effect.
- the reagent will tolerate the addition of various other amines and acids, such as formic acid. Certain compounds, such as acetone, tend to interfere with the color forming reaction and hence should be avoided. To be avoided also are those compounds (e.g., trichloroacetic acid) which tend to precipitate protein from body fluids such as blood serum, since the necessary addition thereto of sufficient dimethylsulfoxide to counteract such precipitants may unduly dilute the color of the solution.
- the quantity of dimethylsulfoxide required in the reagent of the present invention will vary according to the nature of the body fluid tested, the aromatic amine employed, the colored product produced, etc. .It is required only that sufficient dimethylsulfoxide be present to render the aromatic amine, the acid, and the body fluid sample soluble in the reagent to form, upon heating, a colored solution (i.e., a colored fluid having no visually discernable cloudiness).
- the relative quantities of acid and aromatic amine which may be employed in the present invention may vary widely.
- the optimum ratio of acid to amine depends upon the acid and amine chosen, and can be determined by simple experimentation. Normally the quantity of aromatic amine employed is in excess of that theoretically required to react with all of the carbohydrate in the body fluid sample, although lesser quantities of amine may he used. Acid is normally added in sufficient quantity so as to provide maximum coloration of the solution formed upon heating.
- acceptable results have been obtained using a ratio by weight of oxalic acid/otoluidine of from 1/l to 2/1.
- reaction mechanism of the present invention is not completely understood. It is believed, however, that several competing reactions occur, as represented by the following schematic diagrams wherein the carbohydrate, aromatic amine and acid are exemplified by glucose, o-toluidine and oxalic acid respectively.
- Heating of the combined body fluid-reagent may be easily accomplished by means of a boiling water bath, for example, although other methods of heating may be employed.
- the time and temperature required to cause formation of the colored solution will vary according to the contents of the solution.
- the temperature shouldbe sufficiently high to permit a rapid color-forming reaction.
- the use of excessive temperatures or long periods of heating, however, may give rise to decomposition of the dimethylsulfoxide.
- an odor believed to be dimethylsulfide was evolved from a solution of blood serum, oxalic acid, 0- toluidine and dimethylsulfoxide upon prolonged heating of the solution in a boiling water bath.
- Temperatures of from to C. may be successfully employed, although 100 C. (the temperature of boiling water) is preferred. Heating by means of a boiling water bath for a period of 4 to 10 minutes is usually sufficient to develop full color in the solution.
- the colored product from glucuronic acid exhibits distinctive absorption at 530 my, and the colored products of arabinose and xylose exhibit distinctive absorption peaks at 455 my.
- Simultaneous reduction of the data may be accomplished, for example, by the method of Swann, Adams and Well as reported in Analytical Chemistry, Vol. 27, No. 10, pp. 1604-1606 (Oct., 1965).
- the use of oxalic or phosphoric acid in the reagent is especially useful in the determination of such carbohydrates, as explained above.
- the concentrations of glucose were reported in milligrams ofglucose per 100 ml. of plasma.
- Procedure A was repeated 20 times for one sample of blood serum to determine the reproducibility of the procedure. A standard deviation of 0.84 mg./ ml. was obtained.
- Example I A The procedure of Example I A was duplicated on identical samples of blood serum containing glucose, except that various solvents were substituted for portions of the dimethylsulfoxide. Results are presented in Table IV.
- Analytical reagent comprising a solution, in dimethylsulfoxide. of a dimethylsulfoxide-soluble aromatic amine capable of reacting with glucose in the presence ofoxalic acid to form, with heating, a colored product, and a dimethylsulfoxide-soluble acid capable of promoting, with heating, a color-forming reaction between o-toluidine and glucose in dimethylsulfoxide.
- Analytical reagent comprising a solution, in dimethylsulfoxide, of o-toluidine and an acid selected from the group consisting of oxalic acid and phosphoric acid.
- o-toluidine is the sole aromatic amine and wherein said acid is the sole acid in said reagent.
- Analytical reagent comprising a solution, in dimethylsulfoxide, of o-toluidine and oxalic acid, the weight ratio of oxalic acid to o-toluidine being from 1 1 to 2/ l 7.
- the method for the quantitative determination of a body chemical selected from the group consisting of aldopentoses, aldohexoses and their derivatives in a body fluid sample comprising reacting said chemical in a said fluid sample with an aromatic amine to form, with heating, a colored liquid having an optical density dependent upon the concentration of said chemical in said fluid, and measuring the optical density of said colored fluid;'the improvement which comprises carrying out said reaction in dimethylsulfoxide and in the presence of an acid capable, withheating, of promoting said reaction in dimethylsulfoxide.
- Method for the quantitative determination of glucose in a body fluid sample comprising a. combining said body fluid sample with a measured quantity of reagent solution comprising oxalic acid or phosphoric acid, o-toluidine, and dimethylsulfoxide; b. heating the combined body fluid sample and reagent for 4 to 10 minutes at approximately C. to form a colored fluid; c. cooling the colored fluid; and d. measuring the optical density of the colored fluid. 10. Method of claim 9 wherein the weight ratio of oxalic acid to o-toluidine is from 1/1 to 2/1.
- Method for the quantitative photometric determination of a body chemical selected from the group consisting of glucose, glucuronic acid, arabinose, and xylose in a body fluid sample comprising:
- a combining said body fluid sample with a measured quantity of reagent solution comprising, in dimethylsulfoxide. l. a dimethylsulfoxide-soluble aromatic amine capable of reacting with glucose in the presence of oxalic acid to form, with heating, a colored product; and
- an acid selected from the group consisting of oxalic acid and phosphoric acid;
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- Diabetes (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
An analytical reagent and a method for its use in the determination of aldopentoses, aldohexoses, and their derivatives in a body fluid sample. The reagent comprises an acid component, an aromatic amine component, and dimethylsulfoxide.
Description
United States Patent Guehler et al.
[451 Feb. 15, 1972 ANALYTICAL REAGENT AND METHOD FOR CARBOHYDRATE ANALYSIS IN BODY FLUIDS Inventors: Paul F. Guehler, White Bear Lake Township, Ramsey County; John Joseph Neuma'yer, St. Paul, both of Minn.
Assignee: Minnesota Mining and Manufacturing Company, St. Paul, Minn. Filed: May 2, 1969 Appl. No.: 821,470
US. Cl ..23/230 B, 252/408 Int. Cl. ..G0ln2l/24, GOln 31/22, G01n 33/16 Field of Search ..23/253, 230 B; 252/408; 195/ 103.5
References Cited UNITED STATES PATENTS 3,008,879 11/1961 Harvill ..23/230B OTHER PU BLlCATlONS Rees, E. D. et al Chem. Abstract, Vol. 50, p. 14834 Sears. p. G. et al Chem. Abstracts, Vol. 60. p. 15210 Primary Examiner-Morris O. Wolk Assistant Examiner-Elliott A. Katz Attorney-Kinney, Alexander, Sell, Steldt & Delahunt [5 7] ABSTRACT l2 Claim, No Drawings ANALYTICAL REAGENT AND METHOD'FOR CARBOHYDRATE ANALYSIS IN BODY FLUIDS This invention relates to a new and improved reagent and a method for its use in the, quantitative determination of aldopentoses aldohexoses, or their derivatives (e.g., glucose, arabinose, xylose, glucuronic acid, etc.) in a body fluid (e.g., whole blood, blood serum, blood plasma, urine, etc.).
The accurate determination of aldopentoses, aldohexoses and their derivatives in body fluids is of great importance in the diagnosis and control of certain body illnesses. For exam ple, knowledge of the concentration of glucose in urine or blood is of great value to diabetics who must rely on such knowledge in controlling their sugar intake; Similarly, the concentrations of xylose or arabinose in urine may be indicative of pentosuria.
It is especially desirable that such determinations be easily performed with a minimum of manipulations to reduce human error and expense. It is also desirable that the results of such analyses be in close agreement with the results of standard test procedures. For example, it is desirable thata method of glucose analysis be available which yields results in close agreement with results obtainable with the widely employed AutoAnalyzer" (Technicon, Incorporated) thereby permitting glucose determinations to be made. in a hospital laboratory when the AutoAnalyzer is being employed for other purposes.
The AutoAnalyzer analysis for glucose commonly employs a ferricyanide reaction. Manual ferricyanide glucose analyses unfortunately require many manipulations by skilled technicians and are time consuming and expensive. Such analyses are explained in R. J. Henry, Clinical Chemistry: Principles and Techniques, Harper & Row, New York, New York, 1965, pp. 625-627.
Analytical methods for glucose and related chemicals are known, and a number of such methods are explained in Henry, supra., Chapter 19. Such methods are characterized, however, by time-consuming preparations and numerous manipulative procedures.
A photometric procedure for the analysis of glucose which employed an o-toluidine/trichloroacetic' acid reagent was reported by E. Hultman, Nature, 183; 108 (1959). In the Hultman procedure a sample of whole blood was deproteinized by addition of trichloroacetic acid and subsequent centrifugation. To the clear supernate was added o-toluidine in glacial acetic acid. A blue-green color developed in the resulting solution upon heating, and the optical density of the solution at 625 my. was then measured and correlated with the glucose concentration of the blood sample. This procedure, together with certain variations which have been subsequently reported, are characterized by the requirement that protein be precipitated from the body fluid sample and removed by e.g., centrifugation or filtration. Protein appears to interfere with the optical density of the colored solution, and normally causes unduly high optical density readings. Attempts have been made to employ the Hultman procedure without first removing protein. Such methods have attempted to use constant correction factors to compensate for the resultant errors in optical density readings, but entirely satisfactory results have not been obtained. K
It is an object of the present invention to provide a sensitive, simple and economical method for the quantitative determination of aldopentoses, aldohexoses or their derivatives in body fluids.
It is another object of the present invention to provide a novel analytical reagent useful in the method of the present invention.
It is a further object of the present invention to provide a highly sensitive reagent and method for the quantitative photometric determination of glucose in a body fluid.
Briefly, the novel analytical reagent of the present invention comprises a solution of a. dimethylsulfoxide;
b. a dimethylsulfoxide-soluble aromatic amine capable of reacting with glucose in the presence of oxalic acid to form, with heating, acolored product;
c. a dimethylsulfoxide-soluble acid capable of promoting,
with heating, a color-forming reaction between 0- toluidine and glucose in dimethylsulfoxide.
The present invention further relates to an improvement in the method forthe quantitative determination of a body chemical selected from the group consisting of aldopentoses, aldohexoses or their derivatives in a body fluid sample, comprising reacting the body chemical with an aromatic amine to form, with heating, a colored liquid having a optical density dependent upon the concentration of the carbohydrate in the body fluid. The improvement comprises carrying out the reaction in the presence of an acid capable of promoting the reaction in dimethylsulfoxide, and in the presence of sufficient dimethylsulfoxide to render the aromatic amine, the acid, and the body fluid sample soluble in the reagent.
In its preferred embodiment, the method of the present invention may be carried out as follows: 4
a. a measured sample of the body fluid (e.g., blood serum) which contains a carbohydrate (e,.g., glucose) is dissolved in a measured quantity. of a reagent containing;
1. an aromatic amine (e.g., o-toluidine).which.is capable, with heating, of reacting with glucose in the presence of oxalic acid to form a colored reaction product;
2. an acid (e.g., oxalic acid) which is capable of proiriot- ,7
ing, with heating, a color forming reaction betwe'iimtoluidine and glucose in dimethylsulfoxide; and 3. dimethylsulfoxide in sufiicient quantity to render the aromatic amine, the acid, and the body fluid sample soluble in the reagent. b. The resulting solution is heated (e.g., by placing a glass tube containing the solution into boiling water) for a short period (e.g., 4 to 10 minutes) and is then cooled to room temperature. During heating, the reaction between the carbohydrate and the aromatic amine produces a colored product which colors the solution.
c. The optical density of the colored solution is measured at a wavelength which is characteristic of the absorption of the colored product.
d. The measured optical density is correlated with the concentration of the carbohydrate in the body fluid by known means.
Acids which may be employed in the present invention are characterized by their ability to promote a color forming reaction between glucose and o-toluidine in dimethylsulfoxide with heating. Usefulness of a candidate acid in the present invention may be determined as follows: To each of a number of test tubes, each containing ml. of dimethylsulfoxide, is added from 0.01 to 0.25 moles of the candidate acid. Thereafter, to each tube is sequentially added 4.0 ml. of otoluidine and 0.5 ml. of an aqueous glucose solution having a concentration of 100 milligrams ofglucose per 100 ml. of solution. After brief agitation, each tube is heated in boiling water for 6 minutes. Coloration of the solution in any of the tubes indicates that the candidate acid may be employed in the present invention. Examples of such acids include oxalic acid, phosphoric acid, sulfuric acid, phthalic acid and hydrochloric acid. Oxalic and phosphoric acids are especially preferred because the colored solutions which are obtainable through the use of such acids in the dimethylsulfoxide reaction medium unexplainably exhibit much more intense colors than do the colored solutions of Hultman. Such intense coloration appears to depend primarily upon the selection of oxalic or phosphoric acid as the acid component rather than upon the selection of a specific aromatic amine. The intense coloration obtainable by the use of oxalic acid greatly increases the sensitivity of the system and is believed to be primarily responsible for the unusual capability of the present invention t determine the .concentration of such carbohydrates as, for example, arabinose, xylose and glucuronic acid in body fluids. Although the present invention may employ other acids in the detering, a colored product with glucose in the presence of oxalic acid and dimethylsulfoxide. To test the usefulness of a candidate aromatic amine, 4 ml. of the amine are added to 100 ml. of dimethylsulfoxide containing 6.0 g. of oxalic acid in a test tube. To the resulting solution is added 0.5 ml. of an aqueous glucose solution having a concentration of 100 gm. of glucose per 100 ml. of solution. The tube is briefly agitated and is heated in boiling water for 6 minutes-The appearance of a visually colored solution indicates that the candidate aromatic amine may be employed in the present invention. Examples of such aromatic amines include otoluidine, 2,6-dimethyl aniline, and 2,5-dimethyl aniline (as reported by Hultman, supra.) and such other amines as p-bromoaniline, 3,5- dimethyl aniline and 2,4-dimethyl aniline.
The reagent of the present invention will tolerate the inclusion therein of numerous other components. For example, quantities of methanol, ethanol and isopropanol may be added to the reagent without significant adverse effect. The reagent will tolerate the addition of various other amines and acids, such as formic acid. Certain compounds, such as acetone, tend to interfere with the color forming reaction and hence should be avoided. To be avoided also are those compounds (e.g., trichloroacetic acid) which tend to precipitate protein from body fluids such as blood serum, since the necessary addition thereto of sufficient dimethylsulfoxide to counteract such precipitants may unduly dilute the color of the solution.
The quantity of dimethylsulfoxide required in the reagent of the present invention will vary according to the nature of the body fluid tested, the aromatic amine employed, the colored product produced, etc. .It is required only that sufficient dimethylsulfoxide be present to render the aromatic amine, the acid, and the body fluid sample soluble in the reagent to form, upon heating, a colored solution (i.e., a colored fluid having no visually discernable cloudiness).
The relative quantities of acid and aromatic amine which may be employed in the present invention may vary widely. The optimum ratio of acid to amine depends upon the acid and amine chosen, and can be determined by simple experimentation. Normally the quantity of aromatic amine employed is in excess of that theoretically required to react with all of the carbohydrate in the body fluid sample, although lesser quantities of amine may he used. Acid is normally added in sufficient quantity so as to provide maximum coloration of the solution formed upon heating. In the most preferred embodiment of the present invention which employs oxalic acid, o-toluidine and dimethylsulfoxide, acceptable results have been obtained using a ratio by weight of oxalic acid/otoluidine of from 1/l to 2/1.
A weight ratio of oxalic acid/o-toluidine of from l/l to 3/2, however, is preferred. I
The reaction mechanism of the present invention is not completely understood. It is believed, however, that several competing reactions occur, as represented by the following schematic diagrams wherein the carbohydrate, aromatic amine and acid are exemplified by glucose, o-toluidine and oxalic acid respectively.
I Glucose o-toluidine oxalic acid dlmethylsulfoxide S (fast) glucose-o-toluidine product (blue'green) H dimethylsulfoxide oxalic acid II Glucose glucose'o-toluidine (blue-green) dimethylsulfoxide (slow) equilibrium of reaction I is shifted to the right, more colored product is formed. It appears that the equilibrium is shifted to the right by the use of oxalic or phosphoric acids in the present invention, since, as noted above, the use of such acids give rise to intensely colored solutions.
Heating of the combined body fluid-reagent may be easily accomplished by means of a boiling water bath, for example, although other methods of heating may be employed. The time and temperature required to cause formation of the colored solution will vary according to the contents of the solution. The temperature shouldbe sufficiently high to permit a rapid color-forming reaction. The use of excessive temperatures or long periods of heating, however, may give rise to decomposition of the dimethylsulfoxide. In one experiment. for example, an odor believed to be dimethylsulfide was evolved from a solution of blood serum, oxalic acid, 0- toluidine and dimethylsulfoxide upon prolonged heating of the solution in a boiling water bath. Temperatures of from to C. may be successfully employed, although 100 C. (the temperature of boiling water) is preferred. Heating by means of a boiling water bath for a period of 4 to 10 minutes is usually sufficient to develop full color in the solution.
In the method of the present invention, it has been found that if the aromatic amine is added to a heated solution of dimethylsulfoxide and body fluid prior to addition thereto of the acid, little color formation occurs. If, however, the acid is added prior to or concurrently with the aromatic amine, good color formation is obtained, the reason for which is not entirely understood.
Determinations could not easily be made by the Hultman procedure, supra., for such carbohydrates as xylose or arabinose, and could not be made at all for glucuronic acid. Arabinose and xylose normally are found in urine rather than in blood, and present procedures for their analysis are cumbersome and time consuming (see Henry, Clinical Chemistry: Principles and Techniques, supra., pp. 662-664). In the method of the present invention, the optical density of colored fluids produced from these carbohydrates is measured at wavelengths identifiable with such carbohydrates. Using the oxalic acid/dimethylsulfoxide/o-toluidine reagent, for example, the colored product from glucuronic acid exhibits distinctive absorption at 530 my, and the colored products of arabinose and xylose exhibit distinctive absorption peaks at 455 my. Simultaneous reduction of the data may be accomplished, for example, by the method of Swann, Adams and Well as reported in Analytical Chemistry, Vol. 27, No. 10, pp. 1604-1606 (Oct., 1965). The use of oxalic or phosphoric acid in the reagent is especially useful in the determination of such carbohydrates, as explained above.
The present invention may be better understood by reference to the following examples, which are presented for illustrative purposes only and which should not be construed as limiting the scope of the invention.
EXAMPLE I To 4.0 ml. of the above-prepared reagent in a glass tube were added 20 microliters of plasma. The tube was capped and placed in boiling water for 6 minutes. After cooling with cold water for 5 minutes, the optical density of the resulting bluish-green solution was measured at 630 mp. using a Coleman Jr. II spectrophotometer (Perkin-Elmer Corporation) which had been calibrated at zero on thereagent alone. In identical fashion, the optical densities of a series of aqueous 0.2 percent benzoic acid to glucose solutions of known concentration were measured, and a standard curve of glucose concentration versus optical density was graphically prepared therefrom. The standard curve was then employed to relate the concentration of glucose in each of the plasma samples to the opticaldensity of the colored solution prepared therefrom.
B. Hultman Procedure The concentration of glucose in each of the 50 plasma samples was determined by the method set forth in Dubowski, supra. Briefly, this procedure involves precipitating the protein from 20 microliters of blood plasma with 1.8 ml. of 3.0% trichloroacetic acid, filtering out the precipitate, combining 1.0 ml. of the filtrate with 3.0 ml. of 6 percent v/v otoluidine/glacial acetic in a glass tube, immersing the tube for 10 minutes in a 100 C. fluid bath, cooling the tubes, and measuring the optical densities of the solutions at 630mg. Glucose concentration valueswere then derived as in A above.
C. Modified Hultman Procedure The concentration of glucose in each of the 50 plasma samples was measured by the Hultman procedure described in 3" above, except that the step of precipitating protein from the plasma was omitted. I
D. AutoAnalyzer The concentration of glucose in the 50 plasma samples was measured by an AutoAnalyzer (Technicon Incorporated) which employed the ferricyanide reaction.
The concentrations of glucose were reported in milligrams ofglucose per 100 ml. of plasma.
The results obtained by each of procedures A, B and C were separately plotted as ordinates against the AutoAnalyzer results as abscissas on rectangular coordinate paper. Straight lines were drawn through the data points by the method of least squares, each line relating the AutoAnalyzer results with the results respectively obtained by one of the ,above procedures A, B and C. The equation for each line was derived in the form y=mx+b wherein y represents valuesof glucose concentration according to procedures A, 'B and C above, represents values of glucose concentration according to the AutoAnalyzer procedure, m is the slope of the straight line,1|nd b represents the value ofglucose concentration at the point ofinterception of the straight line with the y axis. Perfect agreement between results fromprocedure A and the AutoAnalyzer, for example, would give rise-to a line wherein m=l .0 and wherein b=0 (i.e., y=x). As thevalues ofm and b approach 1.0 and zero, respectively, the agreementbetween the results of the compared methods increases. A correlation coefficient Dixon, W. J. and Massey, F. 1., Introduction to Statistical Analysis, 2nd Ed.,'McGraw-Hill, New York, 1957, Chapter I l) was computed for each comparison. As the value of the correlation coefficient approaches L0, the statistical probability that the compared values are identical increases. Table I lists the values for m and b for the comparisons of procedures A, B and C respectively with procedure D, together with correlation coefficients.
The correlation of procedure (present invention) with procedure D was significantly greater than the correlation of procedure C with procedure D, even though protein was not removed in either of procedures A or C.
Procedure A was repeated 20 times for one sample of blood serum to determine the reproducibility of the procedure. A standard deviation of 0.84 mg./ ml. was obtained.
EXAMPLE I] If the oxalic acid of Example I A is replaced with H 1 0. H 30 phthalic acid or HCl, solutions exhibiting the following colors are obtained (Table II).
TABLE II Acid 8t Quantity Other Reactants Color Obtained 5% (v/v) o-toluidine in dimethylsulfoxide glucose) 4% (v/v) o-toluidine in dimethylsulfoxide glucose) 4% (v/v) o-toluidine in dimethylsult'oxide glucose) 4% (v/v) o-toluidine in dimethylsulfoxide glucose) l.0 M H PO blue red [0% w/v phthalic acid yellow-green 0.36 M HCl red yellow EXAMPLE III The o-toluidine employed in Example I A was replaced with other aromatic amines to provide solutions having the colors set forth in TABLE Ill.
The procedure of Example I A was duplicated on identical samples of blood serum containing glucose, except that various solvents were substituted for portions of the dimethylsulfoxide. Results are presented in Table IV.
TABLE IV Solution Characteristics Solvent (ratio by volume) clear, blue-green clear, hlue-green clear. bluereen dimethylsulfoxide/methanol (2/3) dimethylsulfoxide/ethanol (2/3) dimethylsulfoxide/isopropanol (2/3) dimethylsulfoxide/acetone (3/l no reaction observed dimethylsulfoxide/dimcthylacetamide (H9) green. cloudy EXAMPLE v l The relative sensitivities of the method of the present invention, the method of Hultman, and a modification of the Hultman procedure, were compared as follows: I
To-4.0 ml. of each of the six reagent solutions listed below was added 50 microliters of an aqueous glucose solution containing 102 mg. of glucose per 100 ml. of solution. Each reagent solution was then heated for 6 minutes in boiling water and cooled. The optical density of each solution (less the optical density of the reagent blank) was measured in a 1 cm. cuvette at 630 my. in a Hitachi Model 124 Spectrophotometer (Perkin-Elmer Corporation). The results, which are reported below show the increase in optical density obtained with the method and reagent of the present invention (reagents A-D), as compared to the method of Hultman and a modification thereof (reagents E and F).
Reagent A:
dimethylsulfoxide 50 ml o-toluidine 2g. oxalic acid 3 g.
Optical density at 630 my 0.210
Reagent B:
dimethylsulfoxide 50 ml. o-toluidine 2.5 g. oxalic acid 5.0 g.
Optical density at 630 my, 0450 Reagent C:
dimethylsulfoxide 50 m1. o-toluidine 2 ml. phosphoric acid 4.16 g.
Optical density at 630 mg 0.250
Reagent D:
dimethylsulfoxidc 50 ml. o-toluidine 2 ml. phosphoric acid 6.37 g.
Optical density at 630 mg 0.228
Reagent E:
; acetic acid 50 ml.
o-toluidinc 3.0 ml
Optical density at 630 mg. 0.165
Reagent F:
6% aqueous o-toluidine 50 ml.
3% aqueous lrichloroacctic acid I ml. Optical density at 030 mg 0.125
What is claimed is:
1. Analytical reagent comprising a solution, in dimethylsulfoxide. of a dimethylsulfoxide-soluble aromatic amine capable of reacting with glucose in the presence ofoxalic acid to form, with heating, a colored product, and a dimethylsulfoxide-soluble acid capable of promoting, with heating, a color-forming reaction between o-toluidine and glucose in dimethylsulfoxide.
2. The reagent of claim 1 wherein said acid is selected from the group consisting of phosphoric acid and oxalic acid.
3. The reagent of claim 1 wherein said aromatic amine is otoluidine.
4. Analytical reagent comprising a solution, in dimethylsulfoxide, of o-toluidine and an acid selected from the group consisting of oxalic acid and phosphoric acid.
5. The reagent of claim 4 wherein o-toluidine is the sole aromatic amine and wherein said acid is the sole acid in said reagent.
6. Analytical reagent comprising a solution, in dimethylsulfoxide, of o-toluidine and oxalic acid, the weight ratio of oxalic acid to o-toluidine being from 1 1 to 2/ l 7. 1n the method for the quantitative determination of a body chemical selected from the group consisting of aldopentoses, aldohexoses and their derivatives in a body fluid sample comprising reacting said chemical in a said fluid sample with an aromatic amine to form, with heating, a colored liquid having an optical density dependent upon the concentration of said chemical in said fluid, and measuring the optical density of said colored fluid;'the improvement which comprises carrying out said reaction in dimethylsulfoxide and in the presence of an acid capable, withheating, of promoting said reaction in dimethylsulfoxide.
8. In the method for the quantitative determination of glucose in a body fluid sample comprisingreacting said glucose in said body fluid with o-toluidine to form, with heating, a colored liquid having an optical density dependent upon the concentration of glucose in said body fluid, and measuring the optical density of said colored liquid; the improvement which comprises carrying out said reaction in dimethylsulfoxide and in the presence of an acid selected from the group consisting of oxalic acid and phosphoric acid.
9. Method for the quantitative determination of glucose in a body fluid sample comprising a. combining said body fluid sample with a measured quantity of reagent solution comprising oxalic acid or phosphoric acid, o-toluidine, and dimethylsulfoxide; b. heating the combined body fluid sample and reagent for 4 to 10 minutes at approximately C. to form a colored fluid; c. cooling the colored fluid; and d. measuring the optical density of the colored fluid. 10. Method of claim 9 wherein the weight ratio of oxalic acid to o-toluidine is from 1/1 to 2/1. I
11. Method for the quantitative photometric determination of a body chemical selected from the group consisting of glucose, glucuronic acid, arabinose, and xylose in a body fluid sample comprising:
a. combining said body fluid sample with a measured quantity of reagent solution comprising, in dimethylsulfoxide. l. a dimethylsulfoxide-soluble aromatic amine capable of reacting with glucose in the presence of oxalic acid to form, with heating, a colored product; and
2. an acid selected from the group consisting of oxalic acid and phosphoric acid;
b. heating said combined sample and reagent to provide a solution colored by said colored product; and
c. measuring the optical density of said solution.
12. The method. of claim 11 wherein said aromatic amine is o-toluidine.
Claims (12)
- 2. The reagent of claim 1 wherein said acid is selected from the group consisting of phosphoric acid and oxalic acid.
- 2. an acid selected from the group consisting of oxalic acid and phosphoric acid; b. heating said combined sample and reagent to provide a solution colored by said colored product; and c. measuring the optical density of said solution.
- 3. The reagent of claim 1 wherein said aromatic amine is o-toluidine.
- 4. Analytical reagent comprising a solution, in dimethylsulfoxide, of o-toluidine and an acid selected from the group consisting of oxalic acid and phosphoric acid.
- 5. The reagent of claim 4 wherein o-toluidine is the sole aromatic amine and wherein said acid is the sole acid in said reagent.
- 6. Analytical reagent comprising a solution, in dimethylsulfoxide, of o-toluidine and oxalic acid, the weight ratio of oxalic acid to o-toluidine being from 1/1 to 2/1.
- 7. In the method for the quantitative determination of a body chemical selected from the group consisting of aldopentoses, aldohexoses and their derivatives in a body fluid sample comprising reacting said chemical in a said fluid sample with an aromatic amine to form, with heating, a colored liquid having an optical density dependent upon the concentration of said chemical in said fluid, and measuring the optical density of said colored fluid; the improvement which comprises carrying out said reaction in dimethylsulfoxide and in the presence of an acid capable, with heating, of promoting said reaction in dimethylsulfoxide.
- 8. In the method for the quantitative determination of glucose in a body fluid sample comprising reacting said glucose in said body fluid with o-toluidine to form, with heating, a colored liquid having an optical density dependent upon the concentration of glucose in said body fluid, and measuring the optical density of said colored liquid; the improvement which comprises carrying out said reaction in dimethylsulfoxide and in the presence of an acid selected from the group consisting of oxalic acid and phosphoric acid.
- 9. Method for the quantitative determination of glucose in a body fluid sample comprising a. combining said body fluid sample with a measured quantity of reagent solution comprising oxalic acid or phosphoric acid, o-toluidine, and dimethylsulfoxide; b. heating the combined body fluid sample and reagent for 4 To 10 minutes at approximately 100* C. to form a colored fluid; c. cooling the colored fluid; and d. measuring the optical density of the colored fluid.
- 10. Method of claim 9 wherein the weight ratio of oxalic acid to o-toluidine is from 1/1 to 2/1.
- 11. Method for the quantitative photometric determination of a body chemical selected from the group consisting of glucose, glucuronic acid, arabinose, and xylose in a body fluid sample comprising: a. combining said body fluid sample with a measured quantity of reagent solution comprising, in dimethylsulfoxide,
- 12. The method of claim 11 wherein said aromatic amine is o-toluidine.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82147069A | 1969-05-02 | 1969-05-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US3642444A true US3642444A (en) | 1972-02-15 |
Family
ID=25233482
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US821470A Expired - Lifetime US3642444A (en) | 1969-05-02 | 1969-05-02 | Analytical reagent and method for carbohydrate analysis in body fluids |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US3642444A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4260679A (en) * | 1978-08-01 | 1981-04-07 | Kyowa Hakko Kogyo Co., Ltd. | Method and reagent for the quantitative determination of hydrogen peroxide and precursors thereof |
| EP0029155A1 (en) * | 1979-11-13 | 1981-05-27 | Miles Laboratories, Inc. | Stabilized composition and test device for detecting the presence of a sugar in a test sample |
| US4372874A (en) * | 1976-09-13 | 1983-02-08 | Modrovich Ivan Endre | Stabilization of hydrolysis prone labile organic reagents in liquid media |
| WO1986003585A1 (en) * | 1984-12-11 | 1986-06-19 | Lawrence Paul J | Fecal occult blood test reagents and methods |
| US4818702A (en) * | 1986-06-02 | 1989-04-04 | Litmus Concepts, Inc. | Fecal occult blood test reagent |
| US5866349A (en) * | 1989-04-25 | 1999-02-02 | Lilja; Jan Evert | Method for determination of glucose in whole blood and cuvette and photometer for carrying out said method |
| RU2231786C1 (en) * | 2002-11-27 | 2004-06-27 | Казанский государственный технологический университет | Method of determining hydrocarbon composition of polyphenolic complex of birch mushroom |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3008879A (en) * | 1960-03-18 | 1961-11-14 | Miles Lab | Diagnostic composition for the quantitative determination of glucose |
-
1969
- 1969-05-02 US US821470A patent/US3642444A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3008879A (en) * | 1960-03-18 | 1961-11-14 | Miles Lab | Diagnostic composition for the quantitative determination of glucose |
Non-Patent Citations (2)
| Title |
|---|
| Rees, E. D. et al., Chem. Abstracts, Vol. 50, p. 14834 (1956). * |
| Sears, P. G. et al., Chem. Abstracts, Vol. 60, p. 15210 (1964). * |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4372874A (en) * | 1976-09-13 | 1983-02-08 | Modrovich Ivan Endre | Stabilization of hydrolysis prone labile organic reagents in liquid media |
| US4260679A (en) * | 1978-08-01 | 1981-04-07 | Kyowa Hakko Kogyo Co., Ltd. | Method and reagent for the quantitative determination of hydrogen peroxide and precursors thereof |
| EP0029155A1 (en) * | 1979-11-13 | 1981-05-27 | Miles Laboratories, Inc. | Stabilized composition and test device for detecting the presence of a sugar in a test sample |
| DK156667B (en) * | 1979-11-13 | 1989-09-18 | Miles Inc | METHOD AND TEST MATERIAL FOR DETERMINING THE EXISTENCE OF GLUCOSE IN A TEST |
| WO1986003585A1 (en) * | 1984-12-11 | 1986-06-19 | Lawrence Paul J | Fecal occult blood test reagents and methods |
| US4818702A (en) * | 1986-06-02 | 1989-04-04 | Litmus Concepts, Inc. | Fecal occult blood test reagent |
| US5866349A (en) * | 1989-04-25 | 1999-02-02 | Lilja; Jan Evert | Method for determination of glucose in whole blood and cuvette and photometer for carrying out said method |
| RU2231786C1 (en) * | 2002-11-27 | 2004-06-27 | Казанский государственный технологический университет | Method of determining hydrocarbon composition of polyphenolic complex of birch mushroom |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Goa | A micro biuret method for protein determination Determination of total protein in cerebrospinal fluid | |
| Bergman et al. | Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. | |
| Karvonen et al. | Colorimetric determination of fructose with indol | |
| Trinder | The improved determination of iron in serum | |
| Parker et al. | Improved colorimetric assay for glycosylated hemoglobin. | |
| Trinder | A rapid method for the determination of sodium in serum | |
| Morse | Anthrone in estimating low concentrations of sucrose | |
| Martinen | Improved micro-method for determination of serum bilirubin | |
| Van Kampen et al. | Standardization of hemoglobinometry II. The hemiglobincyanide method | |
| Evans | Manual and automated methods for measuring urea based on a modification of its reaction with diacetyl monoxime and thiosemicarbazide | |
| Kramer et al. | Quantitative determination of glyoxylic acid | |
| US3642444A (en) | Analytical reagent and method for carbohydrate analysis in body fluids | |
| Winsten et al. | A rapid micro diazo technique for measuring total bilirubin | |
| US3795484A (en) | Automated direct method for the determination of inorganic phosphate in serum | |
| Horn et al. | An improved method for the estimation of ammonia in blood plasma | |
| CN110927153A (en) | A method for quantitative or semi-quantitative detection of iodide ion concentration in urine | |
| US3528777A (en) | Process and compositions for determination of uric acid in blood serum | |
| Watson | Enzymic determination of glucose and easily hydrolyzable glucose esters in blood | |
| Momose et al. | Determination of Total Cholesterol in Blood Serum with Perchloric Acid-Phosphoric Acid-Ferric Chloride Reagent. | |
| US3558278A (en) | Determination of albumin | |
| US4211531A (en) | Colorimetric cholesterol assay | |
| EP0418482B1 (en) | Reagent for the detection and determination of bilirubin in the urine | |
| US4526869A (en) | Method for quantitatively determining the concentration of hemoglobin in a biological sample | |
| Uehara et al. | An Improved Method for the Determination of Tyrosine Residues in Proteins Using 1-Nitro-2-napthol | |
| EP0103915B1 (en) | Improved visual reading of colour tests |